AusGeoff wrote on Aug 14
th, 2022 at 10:30am:
John_Taverner wrote on Aug 14
th, 2022 at 7:33am:
If you prefer conspiracy theories, don't open these links:
https://journals.lww.com/jcardiovascularmedicine/Fulltext/2021/09000/Pericarditi... Quote:Pericarditis is a potential presentation of COVID-19. COVID-19 can have an atypical presentation with non-respiratory symptoms. Recognition of an atypical symptom of COVID-19 allows for early isolation and limits the spread.
https://casereports.bmj.com/content/13/8/e237617https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789202/There are very rare cases of pericarditis and myocarditis caused by vaccines. However, Myocarditis and pericarditis occur in the general population from a variety of causes. Not all cases that occur after vaccination are caused by the vaccine.
Myocarditis and pericarditis can also be caused by COVID-19.The vaccine related condition is usually mild, and more often found in younger people (mostly males) under 40.
One of my colleagues who was a super fit athlete at 66 years old, contracted pericarditis after a mild Covid infection (he tested positive for one day only). He had not been vaccinated. He bounced back quickly because of his good general health, but told me he was frustrated at suddenly having to take medications for the first time in his life.
Thank you for bringing a little sanity into this thread John. And of course, yes, we
should be very wary of any
alleged clinical claims in those conspiracy-type videos
the OP has posted.
That there is NO evidence even of what exactly these unnamed conspirators are
talking about, and/or showing makes the entire presentation on Telegram(!) suspect.
The whole thing can safely be ignored as total bullshit.
and so can your convid conspiracy

Cardiovascular Effects of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
https://www.preprints.org/manuscript/202208.0151/v1 Quote:This study focuses on cardiovascular effects, particularly myocarditis and pericarditis events, after BNT162b2 mRNA COVID-19 vaccine injection in Thai adolescents. This prospective cohort study enrolled students from two schools aged 13–18 years who received the second dose of the BNT162b2 mRNA COVID-19 vaccine. Data including demographics, symptoms, vital signs, ECG, echocardiography and cardiac enzymes were collected at baseline, Day 3, Day 7, and Day 14 (optional) using case record forms.We enrolled 314 participants; of these, 13 participants were lost to follow up, leaving 301 participants for analysis. The most common cardiovascular effects were tachycardia (7.64%), shortness of breath (6.64%), palpitation (4.32%), chest pain (4.32%), and hypertension (3.99%). Seven participants (2.33%) exhibited at least one elevated cardiac biomarker or positive lab assessments. Cardiovascular effects were found in 29.24% of patients, ranging from tachycardia, palpitation, and myopericarditis. Myopericarditis was confirmed in one patient after vaccination. Two patients had suspected pericarditis and four patients had suspected subclinical myocarditis. Conclusion: Cardiovascular effects in adolescents after BNT162b2 mRNA COVID-19 vaccination included tachycardia, palpitation, and myocarditis. The clinical presentation of myopericarditis after vaccination was usually mild, with all cases fully recovering within 14 days. Hence, adolescents receiving mRNA vaccines should be monitored for side effects. Clinical Trial Registration: NCT05288231